Influence of Dexmedetomidine on Myocardial Injury in Patients with Simultaneous Pancreas-Kidney Transplantation

Diabetes is one of the most common chronic diseases in the world.End-stage renal disease (esrd) caused by diabetes is the most serious long-term complication.The main cause of death in patients with simultaneous pancreas-kidney transplantation (spkt) is cardiovascular disease.Although dexmedetomidine (dex) has unique advantages in heart protection against ischaemic/reperfusion injury, few clinical studies have been conducted on its cardioprotective effect in spkt.This study aimed to explore the influence of dex on myocardial injury in patients undergoing spkt and to analyze its possible mechanism.Methods.A randomized controlled trial (rct) was performed from july 1, 2018 to december 1, 2020.Eighty patients, regardless of gender, scheduled for spkt were randomly allocated into a dex group (d group) receiving dex at a rate of 1 μg/kg for 10 minutes before anaesthesia induction and then continuous infusion at 0.5 μg/kg/hour until the end of surgery and control group (c group) receiving equivalent capacity of saline.Serum cardiac troponin i (c tn i), creatine kinase isoenzyme (ck-mb), tumour necrosis factor-α (tnf-α), and interleukin-6 (il-6) were recorded at 5 minutes after anaesthesia induction (baseline,t0), 5 minutes before renal arteriovenous opening (t1), 30 minutes after renal arteriovenous opening (t2), 30 minutes after pancreatic related arteriovenous opening (t3), immediately after surgery (t4), 4 hours after surgery (t5), and 24 hours after surgery (t6).Adverse cardiovascular events were recorded during the perioperative period.Changes in ecg s-t segments and t waves were monitored at t0–t6.Myocardial infarction and percutaneous coronary intervention were recorded with an average follow-up of one year.Results.Compared with t0, tnf-α and il-6 concentrations significantly increased at t1–t6 in the c and d groups ( p &lt; 0.05 ).Il-6 concentration increased significantly after renal artery opening and reached the peak after the opening of pancreatic blood vessels.Compared with the c group, tnf-α, and il-6 concentrations were significantly reduced in group d at t2–t6 ( p &lt; 0.05 ).Compared with t0, c tn i and ck-mb concentrations were significantly increased at t3–t6 in the c and d groups ( p &lt; 0.05 ).C tn i and ck-mb concentrations increased significantly after the opening of renal artery, and reached the peak after the opening of pancreatic blood vessels.Compared with the c group, c tn i and ck-mb concentrations were significantly reduced in the d group at t3–t6 ( p &lt; 0.05 ).There was no significant difference in patient characteristics amongst groups, including the proportion of intraoperative vasoactive drug use and adverse cardiovascular events during the follow-up period.Heart rate, mean blood pressure, central venous pressure, and cardiac output were not remarkably different between the two groups at any time point.Conclusions.Perioperative reperfusion could aggravate myocardial injury in spkt.Dex may be considered a way to reduce myocardial injury caused by inflammatory action by decreasing the release of inflammatory factors.Trial registration number: chinese clinical trial registry id: chi ctr2200060084.

Journal: Evidence-Based Complementary and Alternative Medicine (2022)
Publication types: Clinical Study;